PerkinElmer

Bioluminescent Bacteria

OF

Infectious disease is a perennially important area for both life science research and drug discovery. Mimic both acute and chronic standard infection protocols using our bioluminescent light-producing bacteria for infectious disease research.

We provide a wide range of bioluminescent bacteria (Gram-positive and Gram-negative) that can be used for drug discovery both in vitro and in vivo imaging (including biofilm models).

Advantages for drug discovery in vitro:

  • Rapid and readily amenable to HTS
  • Sensitive - subtle changes in cellular viability are rapidly detected
  • Inexpensive - no additional substrates needed for bacterial assays

 

Advantages for drug discovery in vivo:

  • Rapid identification of lead drug candidates
  • Real-time efficacy data
  • May decrease drug failure by allowing disease relapse to be monitored in the same animal

 

For research use only. Not for use in diagnostic procedures.

Products & Services (13)
Filters:

1-12 of 13 Products & Services

Sort by

  • Bioware Bioluminescent Bacteria

    Yersinia enterocolitica - Xen24

    Yersinia enterocolitica - Xen24 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from the 91A1854 clinical isolate. Y. enterocolitica-Xen24 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • S. aureus Bioluminescent Bacteria

    Staphylococcus aureus - Xen36

    Staphylococcus aureus - Xen36 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from a parental strain from the American Type Culture Collection, used under license. Staph. aureus-Xen36 possesses a stable copy of the Photorhabdus luminescens lux operon on the native plasmid.
  • Bioware Bioluminescent Bacteria

    Proteus mirabilis - Xen 44

    Proteus mirabilis - Xen44 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from a parental strain from the American Type Culture Collection, used under license. P. mirabilis-Xen44 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • P. aeruginosa bioluminescent bacteria

    Pseudomonas aeruginosa - Xen05

    P. aeruginosa - Xen05 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from a human septicemia isolate (American Type Culture Collection, used under license). P. aeruginosa-Xen05 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • Bioware Bioluminescent Bacteria

    Listeria monocytogenes - Xen19

    Listeria monocytogenes - Xen19 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from a parental strain from the American Type Culture Collection, used under license. L. monocytogenes-Xen19 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • Bioware Bioluminescent Bacteria

    Yersinia enterocolitica - Xen25

    Yersinia enterocolitica - Xen25 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from the parental strain WS2589. Y. enterocolitica-Xen25 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • Bioware Bioluminescent Bacteria

    Shigella dysenteriae - Xen27

    S. dysenteriae - Xen27 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from the 88A6205 clinical isolate. S. dysenteriae-Xen27 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • S. aureus Bioluminescent Bacteria

    Staphylococcus aureus - Xen29

    Staphylococcus aureus - Xen29 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from a parental strain from the American Type Culture Collection, used under license. Staph. aureus-Xen29 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • S. aureus Bioluminescent Bacteria

    Staphylococcus aureus - Xen40

    Staphylococcus aureus - Xen40 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from the parental strain UAMS-1. Staph. aureus-Xen40 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • P. aeruginosa bioluminescent bacteria

    Pseudomonas aeruginosa - Xen 41

    P. aeruginosa - Xen41 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from parental strain PAO1. P. aeruginosa-Xen41 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • S. aureus Bioluminescent Bacteria

    Staphylococcus aureus - Xen8.1

    Staphylococcus aureus - Xen8.1 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from the parental strain 8325-4. Staph. aureus-Xen8.1 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • S. aureus Bioluminescent Bacteria

    Staphylococcus aureus - Xen31

    Staphylococcus aureus - Xen31 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from a parental strain from the American Type Culture Collection, used under license. Staph. aureus-Xen31 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
  • Jump to: